文献速递主动脉疾病

2区胸主动脉腔内修复术中外科去分支与分支型腔内移植物的比较

Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2022-01-05

单中心回顾性研究比较55例近端2区锚定TEVAR患者,31例接受外科血运重建(SR-TEVAR),24例接受研究性分支型腔内移植物(TBE)。两组手术成功率均100%,围术期卒中和左上肢缺血均为零,TBE组总手术时间和总住院时间显著更短,中期生存、内漏和再干预累积发生率无差异。作者认为TBE可达到与SR-TEVAR相当的手术成功率和安全性,并缩短住院时间,但需前瞻性随机比较。

要点

  • TBE组总手术时间203±79分钟 vs SR-TEVAR组250±79分钟,P=0.03,TBE组更短。
  • TBE组总住院时间5.2±3.6天 vs SR-TEVAR组9.9±7.2分钟(原文此处单位写作分钟),P=0.004。
  • 中期生存(log-rank P=0.50)、器械相关内漏(Fine-Gray P=0.51)和再干预(Fine-Gray P=0.72)无差异。

核心结论

  • 对于需要近端2区覆盖的患者,TBE的手术成功率和安全性与SR-TEVAR相当,且总住院时间更短。
  • 两种入路的中期结局也相似。
  • 作者认为有必要对这两种技术进行前瞻性随机比较。

研究设计与样本

  • 单中心回顾性回顾2014年至2020年连续接受近端2区锚定TEVAR的患者。
  • 比较外科血运重建组(SR-TEVAR组,31例,56%)与研究性分支型腔内移植物组(TBE组,24例,44%)。
  • 排除未接受左锁骨下动脉血运重建的患者。

主要发现

  • 两组手术成功率均为100%,围术期卒中和左上肢缺血事件均为零。
  • 每队列各发生1例手术或30天死亡(TBE组4.2% vs SR-TEVAR组3.2%,P=0.99)。
  • TBE组总手术时间203±79分钟 vs SR-TEVAR组250±79分钟,P=0.03,TBE组更短。
  • TBE组总住院时间5.2±3.6天 vs SR-TEVAR组9.9±7.2分钟(原文此处单位写作分钟),P=0.004,TBE组更短。
  • 中期生存(log-rank检验P=0.50)、器械相关内漏(Fine-Gray检验P=0.51)和再干预(Fine-Gray检验P=0.72)的累积发生率均无差异。

关键数值与推荐

  • 平均随访TBE组28±16个月、SR-TEVAR组34±24个月,期间未发生TBE移植物闭塞或外科旁路/移位闭塞。
  • 左锁骨下动脉血运重建被推荐用于接受择期TEVAR且近端2区锚定需要覆盖左锁骨下动脉的患者。
  • 外科左锁骨下动脉血运重建仍是临床标准治疗。

临床怎么用

  • 对于需要近端2区覆盖的左锁骨下动脉血运重建,TBE可达到与SR-TEVAR相当的手术成功率和安全性,并缩短总住院时间。
  • 作者认为有必要对这两种技术进行前瞻性随机比较。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left subclavian artery (LSA) revascularization has been recommended for patients undergoing elective thoracic endovascular aortic repair (TEVAR) with a proximal zone 2 landing requiring coverage of the LSA. The clinical standard of care remains surgical LSA revascularization. However, recently, the feasibility of using branched endografts has been demonstrated. We compared the perioperative and mid-term outcomes of these approaches. METHODS: We performed a retrospective review of consecutive patients who underwent TEVAR with a proximal zone 2 landing at a single center from 2014 to 2020. The patients were divided into cohorts for comparison: those who underwent surgical revascularization (SR-TEVAR group) and those who underwent thoracic branched endografting with an investigational device (TBE group). Those patients who did not undergo LSA revascularization were excluded. Perioperative outcomes, including procedural success, death, stroke, limb ischemia, and length of stay, were compared. Kaplan-Meier survival curves were compared using the log-rank test. The cumulative incidence of device-related endoleak (types I and III) and device-related reintervention, accounting for death as a competing hazard, were compared using the Fine-Gray test. RESULTS: A total of 55 patients were included: 31 (56%) in the SR-TEVAR group and 24 (44%) in the TBE group. The preoperative demographics and comorbidities were similar between the two groups. Procedural success was 100% in both cohorts, with no periprocedural strokes or left upper extremity ischemic events. One operative or 30-day death (TBE, 4.2%; vs SR-TEVAR, 3.2%; P = .99) occurred in each cohort. The total operative time (TBE, 203 ± 79 minutes; vs SR-TEVAR, 250 ± 79 minutes; P = .03) and total length of stay (TBE, 5.2 ± 3.6 days; vs SR-TEVAR, 9.9 ± 7.2 minutes; P = .004) were both significantly shorter in the TBE group. No difference was found in mid-term survival (log-rank test, P = .50) nor the cumulative incidence of device-related endoleak (Fine-Gray test, P = .51) or reintervention (Fine-Gray test, P = .72). No occlusions of the TBE graft or surgical bypass or transpositions had occurred after a mean follow-up of 28 ± 16 and 34 ± 24 months, respectively. CONCLUSIONS: TBE can be performed with procedural success rate and safety profile comparable to those of TEVAR with surgical revascularization, with a decreased total length of stay, for patients requiring proximal zone 2 coverage. The mid-term outcomes for each approach were also similar. Prospective, randomized comparisons of these techniques are warranted.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Squiers JJ, DiMaio JM, Schaffer JM, et al. Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair. J Vasc Surg. 2022. PMID: 34998942. doi:10.1016/j.jvs.2021.12.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。